Pfizer's revenues in the U.S. and abroad 2009-2023

Revenues generated from outside of the United States accounted for almost two thirds of Pfizer's total revenue in 2023. During that year, the company generated revenues of roughly 31 billion U.S. dollars in countries outside of the United States.

China emerges as important market

Pfizer sells its pharmaceutical products in more than 120 countries worldwide, with the United States, China, and Japan being among the major national markets. In 2023, the United States alone contributed a share of more than 46 percent. In terms of geographic area, emerging markets – which includes China – generated revenues of approximately 12 billion U.S. dollars in 2023.

Analyzing Pfizer’s global operations

In 2023, Pfizer had approximately 88,000 employees worldwide and properties in approximately 90 countries. The American company had around 40 manufacturing sites in countries ranging from Belgium to Singapore, each producing products that service the company’s commercial division. Pfizer also had several facilities that focused on research and development projects, many of which were located in North America.